Viewing Study NCT06946160


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-04-24 @ 5:47 AM
Study NCT ID: NCT06946160
Status: COMPLETED
Last Update Posted: 2025-05-07
First Post: 2025-04-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines
Sponsor:
Organization: